CAMP4 to Participate in the Piper Sandler 36th Annual Healthcare Conference

Core Viewpoint - CAMP4 Therapeutics Corporation is a clinical-stage biotechnology company focused on developing regRNA-targeting therapeutics aimed at restoring healthy protein levels in various genetic diseases [1]. Group 1: Conference Participation - CAMP4 will present and hold one-on-one meetings at the Piper Sandler 36th Annual Healthcare Conference from December 3rd to 5th, 2024 [1]. - The presentation is scheduled for December 5, 2024, from 1:00 to 1:25 PM ET, and a live webcast will be available on the company's investor relations website [2]. Group 2: Company Overview - CAMP4 is developing disease-modifying treatments for over 1,200 genetic diseases by amplifying healthy protein levels through its proprietary RAP Platform™, which targets regRNAs that regulate gene expression [4]. - The company's approach involves using ASO drug candidates to amplify mRNA, which may provide therapeutic benefits in conditions characterized by haploinsufficiency and recessive partial loss-of-function disorders [4].